Study of Capmatinib Efficacy in Comparison With Docetaxel in Previously Treated Participants With Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation

Novartis Investigative Site, Budapest

Novartis Investigative Site, Sofia

Novartis Investigative Site, Sofia

Novartis Investigative Site, Törökbálint

Novartis Investigative Site, Leuven

Novartis Investigative Site, Pleven

Novartis Investigative Site, Port Elizabeth

Novartis Investigative Site, Bangkok

Novartis Investigative Site, Pulau Pinang

Novartis Investigative Site, Berlin

Novartis Investigative Site, Caen

Novartis Investigative Site, Berlin

Novartis Investigative Site, Milan

Novartis Investigative Site, Kuantan

Novartis Investigative Site, Oldenburg

Novartis Investigative Site, Madrid

Novartis Investigative Site, Málaga

Novartis Investigative Site, Oviedo

Novartis Investigative Site, Valencia

Novartis Investigative Site, Kuala Lumpur

Novartis Investigative Site, Cologne

Novartis Investigative Site, Pierre-Bénite

Novartis Investigative Site, Paris

Novartis Investigative Site, Gauting

Novartis Investigative Site, Songkhla

Novartis Investigative Site, Regensburg

Novartis Investigative Site, Hanoi

Novartis Investigative Site, New Delhi

Novartis Investigative Site, Pushkin Saint Petersburg

Novartis Investigative Site, Saint Petersburg

Novartis Investigative Site, Pune

Novartis Investigative Site, Nizhny Novgorod

Novartis Investigative Site, Omsk

Novartis Investigative Site, Barretos

Novartis Investigative Site, São Paulo

Novartis Investigative Site, São Paulo

Novartis Investigative Site, Vellore

Novartis Investigative Site, Roma

Novartis Investigative Site, Vilnius

Novartis Investigative Site, Nijmegen

Novartis Investigative Site, Lisbon

Novartis Investigative Site, Matosinhos Municipality

Novartis Investigative Site, Seoul